Abstract
Cytokines are potent molecules, which function as growth factors and orchestrate both innate and adaptive immune responses. Over the last two decades the number of molecules in this class have greatly expanded, and as the biology of these factors is better understood, several of these factors have entered the clinical arena to support or augment components of the immune response. Recently the use of cytokines - growth factors has been studied in patients without a defective immune system but either have significant infection or infection with drug resistant organisms. The use of cytokines as adjuvants in the treatment of infectious diseases is reviewed both in the context of protein and gene-based therapies.
Keywords: adjuvants, Interferon Gamma, Chemokines, Colony stimulating factors, tumor necrosis, bronchoalvelar lavage fluid, granulocyte macrophage, human growth regulatory, alpha, Inflammatory protein, klebsiella pneumonia, Interleukin, sepsis, Pseudomonas aeruginosa, Mycobacterial infection
Current Pharmaceutical Design
Title: Cytokine Therapeutics for Infectious Diseases
Volume: 6 Issue: 6
Author(s): F. H. Rodriguez, S. Nelson and J. K. Kolls
Affiliation:
Keywords: adjuvants, Interferon Gamma, Chemokines, Colony stimulating factors, tumor necrosis, bronchoalvelar lavage fluid, granulocyte macrophage, human growth regulatory, alpha, Inflammatory protein, klebsiella pneumonia, Interleukin, sepsis, Pseudomonas aeruginosa, Mycobacterial infection
Abstract: Cytokines are potent molecules, which function as growth factors and orchestrate both innate and adaptive immune responses. Over the last two decades the number of molecules in this class have greatly expanded, and as the biology of these factors is better understood, several of these factors have entered the clinical arena to support or augment components of the immune response. Recently the use of cytokines - growth factors has been studied in patients without a defective immune system but either have significant infection or infection with drug resistant organisms. The use of cytokines as adjuvants in the treatment of infectious diseases is reviewed both in the context of protein and gene-based therapies.
Export Options
About this article
Cite this article as:
Rodriguez H. F., Nelson S. and Kolls K. J., Cytokine Therapeutics for Infectious Diseases, Current Pharmaceutical Design 2000; 6 (6) . https://dx.doi.org/10.2174/1381612003400641
DOI https://dx.doi.org/10.2174/1381612003400641 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Correlation between Potassium Channel Expression and Sensitivity to Drug-induced Cell Death in Tumor Cell Lines
Current Pharmaceutical Design Subject Index to Volume 6
Combinatorial Chemistry & High Throughput Screening Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) during Adolescent Brain Development
Current Psychopharmacology Pharmacogenetics in Geriatric Medicine: Challenges and Opportunities for Clinical Practice
Current Drug Metabolism Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Agonists on Glycemic Control, Lipid Profile and Cardiovascular Risk
Current Molecular Pharmacology High Sensitivity C-Reactive Protein as a Potential Biomarker of Neuroinflammation in Major Psychiatric Disorders
Current Psychiatry Reviews A Case of Pantoprazole Anaphylaxis with Cross Reactivity to All Proton Pump Inhibitors: Finding a Safe Alternative
Current Drug Safety Curcumin, an Active Constiuent of the Ancient Medicinal Herb Curcuma longa L.: Some Uses and the Establishment and Biological Basis of Medical Efficacy
CNS & Neurological Disorders - Drug Targets Neuroendocrine Tumors of the Lung: Hystological Classification, Diagnosis, Traditional and New Therapeutic Approaches
Current Medicinal Chemistry Glucocorticoid-induced Tumor Necrosis Factor Receptor Ligand Aggravates Lipopolysaccharide-induced Inflammation by Down-regulating the Programmed Death Ligand in Kupffer Cells
Current Signal Transduction Therapy Over-nutrition, Obesity and Insulin Resistance in the Development of β-Cell Dysfunction
Current Diabetes Reviews Epithelial Cell-Derived Antibacterial Peptides Human β-Defensins and Cathelicidin: Multifunctional Activities on Mast Cells
Current Drug Targets - Inflammation & Allergy Atherosclerosis Neovascularization and Imaging
Current Molecular Medicine Delivery of Large Genomic DNA Inserts > 100 kb Using HSV-1 Amplicons
Current Gene Therapy Changing the Endocrine Dependence of Breast Cancer: Data and Hypotheses
Current Medicinal Chemistry Effect of <i>Umbelliprenin</i> on Antinociceptive Activity of Morphine in a Rat Model of Neuropathic Pain Induced by Chronic Constriction Injury of the Sciatic Nerve
The Natural Products Journal High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC
Current Molecular Medicine Clinical Studies of Renal Nerve Ablation. Unanswered Questions for its Efficacy and Safety
Current Clinical Pharmacology Cerebral Hypoperfusion in Hereditary Coproporphyria (HCP): A Single Photon Emission Computed Tomography (SPECT) Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Vitamin Producing Lactic Acid Bacteria as Complementary Treatments for Intestinal Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry